| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |